Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.025 USD | +2.50% | +16.67% | -25.00% |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
Apr. 26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.00% | 193M | |
+9.33% | 106B | |
+0.86% | 104B | |
+6.78% | 23.25B | |
-13.33% | 22.5B | |
-6.64% | 18.7B | |
-37.08% | 17.95B | |
-11.04% | 16.99B | |
+7.56% | 14.26B | |
+40.06% | 12.76B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- bluebird bio : Finds Reported Case of Leukemia 'Very Unlikely' Related to BB305 Lentiviral Vector; Shares Rise Pre-Bell